DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

192.24 1.86 (0.98%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

JAZZ $192.24 0.98%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $192.48
Previous Close $190.38
Daily Range $190.34 - $194.73
52-Week Range $131.69 - $194.73
Market Cap $11.7B
P/E Ratio 52.45
Dividend (Yield) $0.00 (0.0%)
Volume 392,153
Average Daily Volume 425,656
Current FY EPS $8.68

Sector

Healthcare

Industry

Drug Makers

Jazz Pharmaceuticals, Inc. (JAZZ) Description

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Website: http://www.jazzpharmaceuticals.com/

News & Commentary Rss Feed

This Winning Biotech Stock Looks Like a Buy

Jazz Pharmaceuticals is up more than 20-fold over the past five years, and strong growth in the company's narcolepsy drug Xyrem makes this Foolish contributor believe the good times will continue to roll.

The Wall Street Research Making Waves Today

Jazz Pharma Could Be Worth Over $200 If Xyrem Adds Long-Term Value: Here's How

Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

ETFs For The Next Pharma Takeover Candidates

EWG, DWAQ: Big ETF Inflows

Insider Trading Alert - RGSE, VLGEA And JAZZ Traded By Insiders

Watch Out: Barbarians At The Gate For Jazz Pharmaceuticals (JAZZ)

Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz

Commit To Buy Jazz Pharmaceuticals At $115, Earn 6.8% Using Options

See More JAZZ News...

JAZZ's Top Competitors

JAZZ $192.24 (0.98%)
Current stock: JAZZ
JNJ $100.21 (0.37%)
Current stock: JNJ
NVS $103.75 (0.55%)
Current stock: NVS
RHHBY $36.11 (0.17%)
Current stock: RHHBY